4
Changes in Ownership
Evofem Biosciences, Inc. Filed Acc 0000904454-14-000771
10% owner bought 70,000 shares at $14.00 ($980,000)
- 10% owner gave up 157,317 shares (to pay taxes)
- 10% owner acquired 257,895 shares (option exercise)
- 10% owner acquired 2,921,064 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
DOMAIN PARTERS VII L P · 10% owner
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-11-25 | Conversion : show line 1 in the form | +2,921,064 | 2,921,064 | D | ||
| 2014-11-25 | Exercise or conversion : show line 2 in the form | +92,105 | $8.54 | $786,577 | 3,013,169 | D |
| 2014-11-25 | Shares withheld for taxes : show line 3 in the form | −56,185 | $14.00 | $786,590 | 2,956,984 | D |
| 2014-11-25 | Exercise or conversion : show line 4 in the form | +165,790 | $8.54 | $1,415,847 | 3,122,774 | D |
| 2014-11-25 | Shares withheld for taxes : show line 5 in the form | −101,132 | $14.00 | $1,415,848 | 3,021,642 | D |
| 2014-11-25 | Purchase : show line 6 in the form | +70,000 | $14.00 | $980,000 | 3,091,642 | D |
| Open-market purchases · 70,000 sh · avg $14.00 · $980,000 | ||||||
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-11-25 | Conversion : show line 7 in the form Series A Preferred Stock | −737,422 | 0 | D |
| 2014-11-25 | Conversion : show line 8 in the form Series B Preferred Stock | −6,111,968 | 0 | D |
| 2014-11-25 | Conversion : show line 9 in the form Series B-2 Preferred Stock | −2,164,305 | 0 | D |
| 2014-11-25 | Conversion : show line 10 in the form Series C Preferred Stock | −7,252,144 | 0 | D |
| 2014-11-25 | Exercise or conversion : show line 11 in the form Series B-2 Preferred Stock Warrant (Right to Buy) | −92,105 | 0 | D |
| 2014-11-25 | Exercise or conversion : show line 12 in the form Series C Preferred Stock Warrant (Right to Buy) | −165,790 | 0 | D |
Loading xslF345X03/edgar.xml…